Concise review: Clinical programs of stem cell therapies for liver and pancreas

Stem Cells

Volumn 31, Issue 10, 2013, Pages 2047-2060

  Lanzoni, Giacomo ^a,b   Oikawa, Tsunekazu ^c   Wang, Yunfang ^c,d   Cui, Cai Bin ^c   Carpino, Guido ^e,f   Cardinale, Vincenzo ^f   Gerber, David ^c   Gabriel, Mara ^g   Dominguez Bendala, Juan ^a   Furth, Mark E ^h   Gaudio, Eugenio ^f   Alvaro, Domenico ^f   Inverardi, Luca ^a   Reid, Lola M ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^e UNIVERSITY OF ROME FORO ITALICO   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g MGabriel Consulting   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cell transplantation; DETERMINED (Adult) stem cells; Hematopoietic stem cells; Liver; Mesenchymal stem cells; Pancreas; Tissue regeneration; Tissue specific stem cells

Indexed keywords

CELL POPULATION; CELL RENEWAL; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DUODENUM; EPITHELIAL MESENCHYMAL TRANSITION; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL; HEPATIC ARTERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LIVER CELL; LIVER DEVELOPMENT; LIVER FUNCTION; MESENCHYMAL STEM CELL; PANCREAS CELL; PANCREAS DUCT; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION;

CELL TRANSPLANTATION; DETERMINED (ADULT) STEM CELLS; HEMATOPOIETIC STEM CELLS; LIVER; MESENCHYMAL STEM CELLS; PANCREAS; TISSUE REGENERATION; TISSUE SPECIFIC STEM CELLS;

CELL DIFFERENTIATION; CELL LINEAGE; HEPATITIS; HUMANS; LIVER; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PANCREAS; PANCREATITIS; STEM CELL NICHE;

EID: 84887976409     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1457     Document Type: Review

References (135)

1. Cardinale V, Wang Y, Carpino G et al. Multipotent stem cells in the extrahepatic biliary tree give rise to hepatocytes, bile ducts and pancreatic islets. Hepatology 2011;54:2159-2172.
2. Carpino G, Cardinale V, Onori P et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: An anatomical in situ study yielding evidence of maturational lineages. J Anat 2012;220:186-199.
3. Semeraro R, Carpino G, Cardinale V et al. Multipotent stem/progenitor cells in the human foetal biliary tree. J Hepatol 2012;220:186-199.
4. Wang Y, Lanzoni G, Carpino G et al. Biliary tree stem cells, precursors to pancreatic committed progenitors: Evidence for life-long pancreatic organogenesis. Stem Cells 2013 (in press).
5. Cardinale V, Wang Y, Alpino G et al. The biliary tree: A reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol. 2012;9: 231-240.
6. Furth ME, Wang Y, Cardinale V et al. Stem cell populations giving rise to liver, biliary tree and pancreas. In: Sell S, ed. The Stem Cells Handbook, 2nd ed. New York City, New York: Springer Science Publishers, 2013 in press.
7. Zhang Z, Lin H, Shi M et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decom-pensated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27: 112-120.
8. Amer ME, El-Sayed SZ, El-Kheir WA et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepa-tol 2011;23:936-941.
9. Peng L, Xie DY, Lin BL et al. Autologous bone marrow mesenchy-mal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes. Hepatology 2011;54: 820-828.
10. Parekkadan B, Milwid JM Mesenchymal stem cells as therapeutics. Rev Ann Rev Biomed Eng 2010;12:87-117.
11. Furth ME, Childers MK, Reid LM Stem and progenitor cells in regenerative pharmacology. In: Christ G, Erikson K, eds. Regenerative pharmacology. New York City: Cambridge University Press; 2013 (in press).
12. Peshavaria M, Pang K. Manipulation of pancreatic stem cells for cell replacement therapy. Diabet Technol Therap 2000;2:453-460.
13. Choi JB, Uchino H, Azuma K et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabe-tologia 2003;46:1366-1374.
14. Kharaziha P, Hellstrom PM, Noorinayer B et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009;21:1199-1205.
15. Fukumitsu K, Yagi H, Soto-Gutierrez A. Bioengineering in organ transplantation: Targeting the liver. Transplant Proc 2011;43:2137-2138.
16. Russo FP, Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy 2011;13:135-144.
17. Parveen N, Aleem AK, Habeeb MA et al. An update on hepatic stem cells: Bench to bedside. Curr Pharmacol Biotechnol 2011;12:226-230.
18. Turner R, Lozoya O, Wang YF et al. Hepatic stem cells and maturational liver lineage biology. Hepatology 2011;53:1035-1045.
19. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001;17:387-403.
20. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006;441:1068-1074.
21. Simons BD, Clevers H. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 2011;145:851-862.
22. Solter D. From teratocarcinomas to embryonic stem cells and beyond: A history of embryonic stem cell research. Nat Rev Genet 2006;7:319-327.
23. Evans MJ, Kaufman MH Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
24. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981;78:7634-7638.
25. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
26. Shamblott MJ, Axelman J, Wang S et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 1998;95:13726-13731.
27. Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005;37:1099-1103.
28. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
29. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
30. Kim K, Zhao R, Doi A et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011;29:1117-1119.
31. Zhang D, Jiang W, Liu M et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009;19(4):429-438.
32. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluri-potent stem cells. Nature 2011;474:212-215.
33. Bretzner F, Gilbert F, Baylis F et al. Target populations for first-inhuman embryonic stem cell research in spinal cord injury. Cell Stem Cell 2011;8:468-475.
34. Ichim T, Riordan NH, Stroncek DF The king is dead, long live the king: Entering a new era of stem cell research and clinical development. J Translat Med 2011;9:218.
35. Schulz TC, Young HY, Agulnick AD et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. Plos One 2012;7:e37004.
36. Cherry AB, Daley GQ Reprogrammed cells for disease modeling and regenerative medicine. Ann Rev Med 2013;64:277-290.
37. Zhang L, Theise N, Chua M et al. Human hepatic stem cells and hepatoblasts: Symmetry between liver development and liver regeneration. Hepatology 2008;48:1598-1607.
38. Theise ND, Saxena R, Portmann BC et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999;30:1425-1433.
39. Kuwahara R, Kofman AV, Landis CS et al. The hepatic stem cell niche: Identification by label retaining cell assay. Hepatology 2008; 47:1994-2002.
40. Li L, Xie T. Stem cell niche: Structure and function. Annu Rev Cell Dev Biol 2005;21:605-631.
41. Scadden DT. The stem cell niche as an entity of action. Nature 2006; 441:1075-1079.
42. Yamazaki S, Nakauchi H. Insights into signaling and function of hematopoietic stem cells at the single-cell level. Curr Opin Hematol 2009;16:255-258.
43. Schmelzer E, Zhang L, Bruce A et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204:1973-1987.
44. Wang Y, Yao H-l, Barbier C et al. Lineage-dependent epithelial- mesenchymal paracrine signals dictate growth versus differentiation of human hepatic stem cells to adult fates. Hepatology 2010;52: 1443-1454.
45. Aleem KA, Parveen N, Habeeb MA et al. Journey from hepatocyte transplantation to hepatic stem cells: A novel treatment strategy for liver diseases. Indian J Med Res 2006;123:601-614.
46. Khan AA, Parveen N, Mahaboob VS et al. Management of hyperbi-lirubenemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: A case report. Transplant Proc 2008;40: 1153-1155.
47. Khan AA, Parveen N, Mahaboob VS et al. Treatment of Crigler-Najjar syndrome type 1 by hepatic progenitor cell therapy: A simiple procedure for hyperbilirubinemia. Transplant Proc 2008;40:1148-1150.
48. Khan AA, Parveen N, Mahaboob VS et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: A preliminary study. Transplant Proc 2008;40:1140-1144.
49. De Coppi P., Bartsch G, Jr., Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25: 100-106.
50. Gerlach JC, Over P, Turner ME et al. Perivascular mesenchymal progenitors in human fetal and adult liver. Stem Cells Dev 2012;21: 3258-3269.
51. Crisan M, Corselli M, Chen CW et al. Multilineage stem cells in the adult: A perivascular legacy? Rev Org 2011;7:101-104.
52. Crapnel lK, Blaesius R, Hastings A et al. Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res 2013 (in press).
53. Snykers S, Dekock J, Rogiers V. In vitro differentiation of embryonic and adult stem cells into hepatocytes: State of the art. Stem Cells 2009;27:577-605.
54. Caplan AICD. The MSC. an injury drugstore. Cell Stem Cell 2011;9: 11-15.
55. Caplan AI, Bruder SP Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trend Mol Med 2001;7:259-264.
56. Houlihan DD, Newsome PN Critical review of clinical trials of bone marrow stem cells in liver disease. Rev Gastroenterol 2008;135:438-450.
57. Wood JA, Colletti E, Mead LE et al. Distinct contribution of human cord blood-derived endothelial colony forming cells to liver and gut in a fetal sheep model. Hepatology 2012;56:1086-1096.
58. Talebi S, Aleyasin A, Soleimani M et al. Derivation of islet-like cells from mesenchymal stem cells using PDX1-transducing lentiviruses. Biotechnol Appl Biochem 2012;59:205-212.
59. Caplan AI. Why are MSCs therapeutic? New data: New insight review. J Pathol 2009;217:318-324.
60. Zhang Z, Wang F. Stem cell therapies for liver failure and cirrhosis. J Hepatol 2013 (in press).
61. Forbes S, Newsome PN New horizons for stem cell therapy in liver disease. Review. J Hepatol 2012;56 496-499.
62. Bianco P, Cao X, Frenette PS et al. The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 2013;19:35-42.
63. Zorn AM, Wells JM Molecular basis of vertebrate endoderm development. Int Rev Cytol 2007;259:49-111.
64. Lange AW, Keiser AR, Wells JM et al. Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium. Plos One 2009;4: e5711.
65. Snyder JC, Teisanu RM, Stripp BR Endogenous lung stem cells and contribution to disease. J Pathol 2009;217:254-264.
66. Barker N, Huch M, Kujala P et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010;6:25-36.
67. Tremblay KD, Zaret KS Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Dev Biol 2005;280:87-99.
68. Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev 2008;22:1856-1864.
69. McLin VA, Zorn AM Organogenesis: Making pancreas from liver. Curr Biol 2003;13:R96-98.
70. Sinner D, Rankin S, Lee M et al. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 2004;131:3069-3080.
71. Zaret K. Developmental competence of the gut endoderm: Genetic potentiation by GATA and HNF3/fork head proteins. Dev Biol (Orlando) 1999;209:1-10.
72. Wandzioch E, Zaret KS Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 2009; 324:1707-1710.
73. Chung WS, Shin CH, Stainier DY Bmp2 signaling regulates the hepatic versus pancreatic fate decision. Dev Cell 2008;15:738-748.
74. Pan FC, Wright C. Pancreas organogenesis: From bud to plexus to gland. Dev Dynamics 2011;240:530-565.
75. Sicklick JK, Li YX, Melhem A et al. Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol gastrointestinal Liver Physiol 2006;290:G859-G870.
76. McClelland R, Wauthier E, Uronis J et al. Gradient in extracellular matrix chemistry from periportal to pericentral zones: Regulation of hepatic progenitors. Tissue Eng 2008;14:59-70.
77. Kubota H, Yao H, Reid LM Identification and characterization of vitamin A-storing cells in fetal liver. Stem Cells 2007;25:2339-2349.
78. Carpentier R, Suñer RE, van Hul N et al. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology 2011;141:1432-1438.
79. Furuyama K, Kawaguchi Y, Akiyama H et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 2011;43:34-41.
80. Kawaguchi Y. Sox9 and programming of liver and pancreatic progenitors. J Clin Invest 2013;123:1881-1886.
81. Swenson ES, Xanthopoulos J, Nottoli T et al. Chimeric mice reveal clonal development of pancreatic acini, but not islets. Biochem Bio-phys Res Commun 2009;379:526-531.
82. Schmelzer E, Wauthier E, Reid LM Phenotypes of pluripotent human hepatic progenitors. Stem Cell 2006;24:1852-1858.
83. Dor Y, Brown J, Martinez OI et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-46.
84. Houbracken I, Bouwens L. The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement., 112-123. Rev Diabet Studies 2010;7:112-123.
85. Xu X, D'Hoker J, Stange G et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008; 132:197-207.
86. Malato Y, Naqvi S, Schürmann N et al. Fate tracing of mature hepa-tocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011;121:4850-4860.
87. Bonner-Weir S., Weir GC. New sources of pancreatic beta cells. Nat Biotechnol 2005;23:857-861.
88. Lemaigre F. Lineage fate decisions in normal and regenerating liver [article in French]. Med Sci (Paris) 2012;28:958-962.
89. Diehl AM, Chute J. Underlying potential: Cellular and molecular determinants of adult liver repair. J Clin Invest 2013;123:1858-1860.
90. Kordes C, Haussinger D. Hepatic stem cell niches. J Clin Invest 2013;123:1874-1880.
91. Huch M, Dorrell C, Boj SF et al. In vitro expansion of single Lgr5 + liver stem cells induced by Wnt-driven regeneration. Nature 2013; 494:247-250.
92. Yin C, Evason KJ, Asahina K et al. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 2013;123:1902-1910.
93. DeLeve LD. Liver sinusoidal endothelial cells and liver regeneration. J Clin Invest 2013;123.
94. Saxena R, Theise N. Canals of Hering: Recent insights and current knowledge. Sem Liver Disease 2004;24:43-48.
95. Strobel O, Rosow DE, Rahaklin EY et al. Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology 2010;138:1166-1177.
96. Kushner JA, Weir GC, Bonner-Weir S. Ductal origin hypothesis of pancreatic regeneration under attack. Cell Metab 2010;11:2-3.
97. Bonner-Weir S., Tosch iE, Inada A et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabet 2004;5:16-22.
98. Leeson TS, Leeson CR The fine structure of Brunner's glands in man. J Anat 1968;103:263-276.
99. Nakanuma Y, Hoso M, Sanzen T., Sasaki, M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. A review. Microsc Res Tech 1997;15:552-570.
100. Nakanuma Y, Katayanagi K, Terada T et al. Intrahepatic peribiliary glands of humans. I. Anatomy, development and presumed functions. A review. J Gastroenterol Hepatol 1994;9:75-79.
101. Nakanuma Y, Sasaki M, Terada T et al. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol 1994;9:80-86.
102. Oikawa T, Kamiya A, Zeniya M et al. SALL4, a stem cell biomarker for liver cancers. Hepatology 10.1002/hep.26159, 57:1469-1483.
103. Stachelscheid H, Urbaniak T, Ring A et al. Isolation and characterization of adult human liver progenitors from ischemic liver tissue derived from therapeutic hepatectomies. Tissue Eng Part A 2009;15: 1633-1643.
104. Dollé L, Best J, Empsen C et al. Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naive mice. Hepatology 2012;55:540-552.
105. Schmelzer E, Reid LM Telomerase activity in human hepatic stem cells, hepatoblasts and hepatocytes from neonatal, pediatric, adult and geriatric donors. Eur J Hepatol Gastroenterol 2009;21:1191-1198.
106. Kubota H, Reid LM Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 2000;97:12132-12137.
107. Wauthier E, McClelland R, Turner W et al. Hepatic stem cells and hepatoblasts: Identification, isolation and ex vivo maintenance. Methods Cell Biol 2008;86:137-225.
108. McClelland R, Wauthier E, Zhang L et al. Ex vivo conditions for self-replication of human hepatic stem cells. Tissue Eng 2008; 14:1-11.
109. Wang Y, Cui C, Miguez P et al. Lineage restriction of hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011;53:293-305.
110. Habibullah CM, Syed IH, Qamar A et al. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994;58:951-952.
111. Khan AA, Shaik MV, Parveen N et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 2010;19: 1-10.
112. Turner R, Gerber D, Reid LM Transplantation of cells from solid organs requires grafting protocols. Transplantation 2010;90:807-810.
113. Turner R, Wauthier E, Lozoya O et al. Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts. Hepatology 2013;57:775-784.
114. Taylor CJ, Bolton EM, Pocock S et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025.
115. Zheng YB, Zhang XH, Huang Z.L., Lin CS, Lai J, Gu YR, et al Amniotic fluid-derived mesenchymal stem cells over-expressing inter-leukin 1 receptor antagonist improve fulminant hepatic failure. PLOS One 2013;7:e41392.
116. Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diabetes Report 2011; 11:345-354.
117. Dominguez-Bendala J., Inverardi L, Ricordi C. Regeneration of pancreatic beta-cell mass for the treatment of diabetes. Expert Opin Biol Therapies 2012;12:731-741.
118. Hebrok M. Generating beta cells from stem cells-the story so far. Cold Spring Harbor Perspect Med 2012;2:a007674.
119. Kroon E, Martinson LA, Kadoya K et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnol 2008;26: 443-452.
120. Dominguez-Bendala J., Inverardi L, Ricordi C. Stem cell-derived islet cells for transplantation. Curr Opin Organ Transplant 2010;12:731-741.
121. Poggioli R, Faradji RN, Ponte G et al. Quality of life after islet transplantation. Am J Transplant 2006;6:371-378.
122. Ricordi C, Strom TB Clinical islet transplantation: Advances and immunological challenges. Nat Rev Immunol 2004;4:259-268.
123. Thompson DM, Meloche M, Ao Z et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 2011;91:373-378.
124. Leitao CB, Cure P, Tharavanij T et al. Current challenges in islet transplantation. Curr Diabetes Report 2008;8:324-331.
125. Harlan DM, Kenyon NS, Korsgren O et al. Current advances and travails in islet transplantation. Diabetes 2009;58:2175-2184.
126. Dominguez-Bendala J., Lanzoni G, Inverardi L et al. Concise review: Mesenchymal stem cells for diabetes. Stem Cell Translational Med 2012;1:59-63.
127. Figueroa FE, Carrion F, Villanueva S et al. Mesenchymal stem cell treatment for autoimmune diseases: A critical review. Biol Res 2012; 45:269-277.
128. Tolar J, Le Blanc K, Keating A et al. Concise review: Hitting the right spot with mesenchymal stromal cells. Stem Cells 2010;28: 1446-1455.
129. Liu X, Wang Y, Li Y et al. Research status and prospect of stem cells in the treatment of diabetes mellitus. Sci China Life Sci 2013; 56:206-312.
130. Robinton DA, Daley GQ The promise of induced pluripotent stem cells in research and therapy. Rev Nat 2012;481:295-305.
131. Van Belle T., von Herrath M. Immunosuppression in islet transplantation. J Clin Invest 2008;118:1625-1628.
132. Hirano S, Tanaka EM, Tsuchikawa T et al. Techniques of biliary reconstruction follwing bile duct reserction (with video). Rev J Hepa-tobiliary Pancreatic Sci 2012;19:203-209.
133. de Reuver P.R., Busch OR, Rauws EA et al. Long-term results of a primary end-to-end anastomosis in peroperative detected bile duct injury. J Gastrointestinal Surgery 2007;11:296-302.
134. Barton FB, Rickels MR, Alejandro R et al. Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 2012;35: 1436-1445.
135. Takebe T, Sekine K, Enomura M., Koike H, Kimura M, Ogaeri T., et al Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013;499:In Press (epublication July 3rd).